Amnio Technology, LLC Announces the Initiation of a Phase 2 Clinical Trial to Evaluate PalinGen® Flow for the Treatment of Venous Stasis and Diabetic Ulcers

PHOENIX, Nov. 4, 2020 /PRNewswire/ -- Amnio Technology, LLC, a global leader in the development and distribution of amniotic tissue allografts, is announcing today that it has received authorization from FDA to proceed with a Phase 2 clinical trial under an Investigational New Drug (IND)...

from PR Newswire: https://ift.tt/3p0AX0k